Biological Effects of Hydrogen Water on Subjects with NAFLD: A Randomized, Placebo-Controlled Trial

• Үндсэн зохиолчид: Branislav Kura (Зохиогч), Maria Szantova (Зохиогч), Tyler W. LeBaron (Зохиогч), Viliam Mojto (Зохиогч), Miroslav Barancik (Зохиогч), Barbara Szeiffova Bacova (Зохиогч), Barbora Kalocayova (Зохиогч), Matus Sykora (Зохиогч), Ludmila Okruhlicova (Зохиогч), Narcisa Tribulova (Зохиогч), Anna Gvozdjakova (Зохиогч), Zuzana Sumbalova (Зохиогч), Jarmila Kucharska (Зохиогч), Xenia Faktorova (Зохиогч), Martina Jakabovicova (Зохиогч), Zuzana Durkovicová (Зохиогч), Jan Macutek (Зохиогч), Michaela Koscová (Зохиогч), Jan Slezak (Зохиогч)
• Формат: Ном
• Хэвлэсэн: MDPI AG, 2022-09-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Non-alcoholic fatty liver disease (NAFLD) is a liver pathology affecting around 25% of the population worldwide. Excess oxidative stress, inflammation and aberrant cellular signaling can lead to this hepatic dysfunction and eventual carcinoma. Molecular hydrogen has been recognized for its selective...